Simultaneous multimodality molecular imaging with neodymium-doped Y3Al5O12 nanoparticles
YONGHUA ZHAN1,
XU CAO1,
XIN CAO1,
FEI KANG2,
JING WANG2,
JIMIN LINAG1,
ZHIMIN LI3,*
,
XUELI CHEN1,*
Affiliation
- Engineering Research Center of Molecular and Neuro Imaging of the Ministry of Education & School of Life Science and Technology, Xidian University, Xi’an, Shaanxi 710071, China
- Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China
- School of Advanced Materials and Nanotechnology, Xidian University, Xi’an, Shaanxi710071, China
Abstract
Capturing simultaneously multimodality information using one imaging agent is a new direction of molecular imaging technology. In this work, we report a proof-of-concept study that uses trimodality imaging consisting of fluorescence imaging (FI), X-ray excited luminescence imaging (XEL), and radionuclide excited luminescence imaging (REL), with the injection of only one kind of Nd3+:Y3Al5O12 nanoparticles. The spectrum measurements and the results of in vivo pseudo-tumor based experiments validated the capability of Nd3+:Y3Al5O12 nanoparticles as agents for trimodality imaging. This proof-of-concept study may open the door for the rapid development of multimodality imaging technology that facilitates the acquisition of a large novel information to be simultaneously obtained using one imaging agent and one imaging system..
Keywords
Multimodality imaging, Simultaneous imaging, Nd3+:Y3Al5O12 nanoparticles.
Citation
YONGHUA ZHAN, XU CAO, XIN CAO, FEI KANG, JING WANG, JIMIN LINAG, ZHIMIN LI, XUELI CHEN, Simultaneous multimodality molecular imaging with neodymium-doped Y3Al5O12 nanoparticles, Optoelectronics and Advanced Materials - Rapid Communications, 10, 9-10, September-October 2016, pp.685-688 (2016).
Submitted at: Oct. 22, 2015
Accepted at: Sept. 29, 2016